TY - CHAP
T1 - Drug Receptor Interactions and Physicochemical Forces
AU - Yang, Siyun
AU - Kar, Supratik
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.
PY - 2025
Y1 - 2025
N2 - The study of drug-receptor interactions is pivotal in understanding the molecular mechanisms underlying drug efficacy and safety. This chapter provides a comprehensive examination of the various types of drug targets, including enzymes, ion channels, G-protein coupled receptors, tyrosine kinase receptors, intracellular receptors, nuclear receptors, and cytokine receptors, as well as transport and structural proteins, nucleic acids, carbohydrates, and lipids. It delves into the physicochemical forces such as covalent interactions, hydrogen bonds, electrostatic interactions, hydrophobic interactions, Van der Waals forces, and cation-π and π-π interactions that govern these interactions. The chapter also highlights the importance of these forces in the context of drug design and lead optimization, emphasizing the structure-activity relationship (SAR) and pharmacophore modeling. By elucidating the intricate dynamics of ligand-receptor binding, this work aims to inform the design of more effective, bioavailable, and safer therapeutic agents, with a focus on improving absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles.
AB - The study of drug-receptor interactions is pivotal in understanding the molecular mechanisms underlying drug efficacy and safety. This chapter provides a comprehensive examination of the various types of drug targets, including enzymes, ion channels, G-protein coupled receptors, tyrosine kinase receptors, intracellular receptors, nuclear receptors, and cytokine receptors, as well as transport and structural proteins, nucleic acids, carbohydrates, and lipids. It delves into the physicochemical forces such as covalent interactions, hydrogen bonds, electrostatic interactions, hydrophobic interactions, Van der Waals forces, and cation-π and π-π interactions that govern these interactions. The chapter also highlights the importance of these forces in the context of drug design and lead optimization, emphasizing the structure-activity relationship (SAR) and pharmacophore modeling. By elucidating the intricate dynamics of ligand-receptor binding, this work aims to inform the design of more effective, bioavailable, and safer therapeutic agents, with a focus on improving absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles.
KW - Drug optimization
KW - Drug targets
KW - Drug-receptor interaction
KW - Physicochemical forces
UR - https://www.scopus.com/pages/publications/105026585403
U2 - 10.1007/978-3-031-81728-1_2
DO - 10.1007/978-3-031-81728-1_2
M3 - Chapter
AN - SCOPUS:105026585403
T3 - Springer Handbooks
SP - 45
EP - 62
BT - Springer Handbooks
PB - Springer Science and Business Media Deutschland GmbH
ER -